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Abstract Many different measures have been found to be
related to behavioral outcome after stroke. Preclinical
studies emphasize the importance of brain injury and
neural function. However, the measures most important to
human outcomes remain uncertain, in part because studies
often examine one measure at a time or enroll only mildly
impaired patients. The current study addressed this by
performing multimodal evaluation in a heterogeneous
population. Patients (n = 36) with stable arm paresis
3–6 months post-stroke were assessed across 6 categories
of measures related to stroke outcome: demographics/
medical history, cognitive/mood status, genetics, neuro-
physiology, brain injury, and cortical function. Multivariate
modeling identified measures independently related to an
impairment-based outcome (arm Fugl-Meyer motor score).
Analyses were repeated (1) identifying measures related to
disability (modified Rankin Scale score), describing inde-
pendence in daily functions and (2) using only patients
with mild deficits. Across patients, greater impairment was
related to measures of injury (reduced corticospinal tract
integrity) and neurophysiology (absence of motor evoked
potential). In contrast, (1) greater disability was related to
greater injury and poorer cognitive status (MMSE score)
and (2) among patients with mild deficits, greater
impairment was related to cortical function (greater con-
tralesional motor/premotor cortex activation). Impairment
after stroke is most related to injury and neurophysiology,
consistent with preclinical studies. These relationships vary
according to the patient subgroup or the behavioral end-
point studied. One potential implication of these results is
that choice of biomarker or stratifying variable in a clinical
stroke study might vary according to patient characteristics.
Keywords Neuroimaging  Impairment  Disability 
Stratification  Biomarker  Motor system
Introduction
Behavioral outcomes after stroke show substantial variation
across patients. Many factors contribute to this, including
differences between patients prior to stroke, in the stroke
injury itself and in post-stroke brain plasticity. Inter-subject
variability in patients with stroke complicates efforts to
evaluate new therapies, including efforts to stratify patients
in clinical trials [1] or to develop reliable biomarkers [2].
Numerous measures have been found to correlate with
outcome after stroke in humans. Examples include age [3],
comorbidities such as diabetes [4], cognitive status [5],
depression [6], and genetic variation [7] as well as neuro-
imaging measures such as infarct volume [8], corticospinal
tract (CST) integrity [9], and cortical function [10]. How-
ever, the measures most critical to outcomes in patients
with stroke remain uncertain, in part because few studies
have examined multiple variables in parallel. A multimodal
approach could help identify the factors most closely
linked with behavioral outcome after stroke.
The current study adopted such a multimodal approach,
with a focus on the motor system. In a cohort of patients who
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reached a plateau in behavioral recovery after stroke, variables
in 6 categories were measured: demographics/history, cog-
nitive/mood, genetic, neurophysiology, brain injury, and
cortical function. The primary study hypothesis, based on the
preclinical literature [11–13], was that measures of brain
injury and neural function would have the strongest relation-
ships with final level of motor impairment after stroke.
Two secondary hypotheses were also examined. The first
was that the correlates of motor outcome after stroke vary in
relation to severity of the deficits. The heterogeneity of
stroke in humans suggests that differences may exist in the
biology of recovery across patient subgroups. A better
understanding of biological differences in stroke subgroups
might inform (1) stratification approaches in clinical trials of
restorative therapies after stroke and (2) the extent to which
published reports generalize, given that many prior studies
have focused on patients with mild deficits [14]. The second
hypothesis was that the correlates of motor outcome after
stroke vary across dimensions of the World Health Organi-
zation International Classification of Functioning, Disabil-
ity, and Health (WHO ICF) [15]. Specifically, correlates of
impairment (loss of body functions and structures) are
hypothesized to differ from correlates of disability (activities
limitations). Less is known about the neurobiological basis
of post-stroke disability, as compared to impairment,
although such information is important given that measures
of disability are directly linked with patient functional status
[16] and that such measures have only a limited relationship
with level of impairment.
Materials and methods
Patients
Forty-one patients with stable motor deficits early after
stroke were recruited. Inclusion and exclusion criteria appear
in Table 1. Of the 41 enrollees, 4 could not complete MRI
due to claustrophobia/anxiety and 1 was found ineligible
after baseline assessments, leaving 36 patients (Table 2). All
patients provided informed consent. The study was approved
by the UC Irvine Institutional Review Board.
Demographics/history
Medical history was obtained, and hospitalization records
were reviewed.
Cognitive/mood status
A single rater performed all behavioral assessments, which
included Mini-Mental State Exam (MMSE) and Geriatric
Depression Scale [17].
At this exam, impairment was measured using the arm motor
Fugl-Meyer (FM) scale [18], and disability, using the modified
Rankin Scale (mRS) [19]. Stable arm motor status was opera-
tionally defined by obtaining a second baseline FM score
7–21 days after the first; stability was present if the second FM
score was within 3 points of the first. Handedness was deter-
mined using the Edinburgh Handedness Inventory [20].
Genetics
A blood sample was obtained, and presence of the brain-
derived neurotrophic factor (BDNF) val66met polymor-
phism and the ApoE4 allele was each determined, as
described previously [7].
Neurophysiology
Patients underwent transcranial magnetic stimulation
(TMS) of ipsilesional motor cortex. Motor evoked potential
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Age C18 years Contraindication to MRI
Diagnosis of stroke 11–26 weeks prior Severe cognitive
impairment
Residual arm motor deficit (ARAT
\52 or 9-hole peg test score [25 %
longer than with unaffected hand)
Concurrent diagnosis
affecting arm/hand
function
Preserved voluntary movements in
distal upper extremity (C5 range of
motion in affected index
metacarpophalangeal joint or wrist)
Arm motor status not at
stable plateau
Table 2 Patient characteristics
Age (years) 58.4 ± 13.8 (21–86)
Gender 10 F/26 M
Time post-stroke (months) 4.4 ± 1.1 (2.5–6.0)
Handedness 2 L/34 R
Diabetes mellitus 10 Y/26 N
Hypertension 18 Y/18 N
Hypercholesterolemia 16 Y/20 N
Fugl-Meyer arm motor score 35.0 ± 14.5 (14–60)
Mini-Mental State Exam 28 [25–30]
Geriatric Depression Scale 2.5 [1.25–4.75]
BDNF val66met polymorphism present 11 Y/25 N
ApoE4 allele present 8 Y/28 N
Side of stroke 19 L/17 R
Infarct volume (cc) 31.7 ± 48.6 (0.5–178)
For the 36 individuals with stroke, values presented are mean ± SD
(range) or median [IQR]. For the FM scale, normal score is 66; for
MMSE, 30; for both, higher score is better. For the Geriatric
Depression Scale, normal score is 0 and lower score is better
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(MEP) amplitudes were measured in the paretic first dorsal
interosseous muscle at rest [21]. In sum, the site of lowest
motor threshold (LMT) in the ipsilesional hemisphere that
elicited a suprathreshold response of 0.5 lV [22] in the
stroke-affected first dorsal interosseus (FDI) muscle at rest
was identified. If an LMT was found, TMS was applied at
four stimulus intensities (90, 110, 130, and 150 %). If an
MEP was detectable, reflecting neurophysiological integ-
rity, latency to MEP was calculated (measured in ms,
determined at 110 % of resting motor threshold and
reflecting speed of motor system conduction), as well as the
input/output recruitment curve (which finds the slope of the
plot looking at MEP in relation to the 4 TMS stimulation
levels and reflects recruitment and reserve of stimulation
targets [22, 23]). Presence of a TMS-elicited MEP was also
categorized as present or absent. If no MEP greater than
0.5 lV was elicited in and around motor cortex after four
stimulations at the maximum output of the TMS coil, then
MEP was defined as absent. For maximal safety, subjects
did not undergo TMS if contraindicated, e.g., due to cal-
varial defect or usage of certain medications [21, 24]. Due
to these criteria, 16 subjects did not undergo TMS.
Brain injury
Image acquisition: MRI images were acquired using a 3.0T
Philips Achieva system. Imaging included both anatomical
(high-resolution T1-weighted images, T2-FLAIR, and dif-
fusion tensor imaging (DTI)) and functional MRI (fMRI).
For the T1-weighted image, parameters included repetition
time (TR) = 8.5 ms, echo time (TE) = 3.9 ms, sli-
ces = 150, and voxel size = 1 9 1 9 1 mm3. For the T2-
FLAIR image, parameters included TR = 11,000 ms,
TE = 125 ms, slices = 31 slices, and voxel size =
0.58 9 0.58 9 5 mm3. One set of diffusion-weighted
images was acquired using 32 directions, b-value
1,000 smm-2, 60 slices, and voxel size = 1.75 9 1.75 9
2 mm3.
Image analysis: Image analysis was performed blinded
to clinical data. In sum, three classes of brain injury metrics
were extracted: (1) total brain injury (infarct volume); (2)
gray matter injury (to primary motor cortex (M1), to dorsal
premotor cortex (PMd), and total cortical injury); and (3)
white matter injury (overlap with corticospinal tract (CST)
and per DTI fractional anisotropy (FA) values within ip-
silesional cerebral peduncle).
Infarct volume: Using the MRI image analysis program
MRIcron (http://www.mccauslandcenter.sc.edu/mricro/mri
cron), each subject’s infarct was outlined by hand on the
T1-weighted MRI image, as informed by the T2-FLAIR
image. All areas of injured tissue (i.e., the infarct core and
surrounding diffuse white matter injury) were included.
When multiple spatially separate foci of injury were
present, they were all summed into a single-stroke mask.
The resulting stroke masks were binarized and then spa-
tially transformed into MNI standard stereotaxic space
using FSL. We have found good intra-rater reliability
(Pearson’s r = 0.998, p \ 0.0001; intraclass correlation
coefficient = 0.998) and inter-rater reliability (r = 0.994,
p \ 0.0001; intraclass correlation coefficient = 0.98) with
this method, in a separate analysis of 10 subjects who were
3–6 months post-stroke.
Gray matter injury: To determine the contribution of
gray matter motor system injury to behavioral gains, each
patient’s baseline T1-weighted image was inspected to
evaluate stroke-related injury to cortex of M1 (i.e., pre-
central gyrus), cortex of PMd, and the entire cerebral
cortex. The regions of interest (ROI) for M1 and for PMd
were drawn on the 1 9 1 9 1 mm MNI T1 template in
FSL. The M1 ROI consisted of the posterior bank of the
precentral gyrus, whereas the PMd ROI consisted of the
posterior bank of the middle frontal gyrus anterior to the
precentral sulcus. The cerebral cortex ROI was generated
by segmenting the same MNI template using the FAST
module and isolating the segmented deep gray matter. Each
patient’s stroke mask was transformed into MNI space
using the same template. Those two images were then
multiplied to generate an overlap image. The number of
voxels of the infarct that overlapped with the ROIs was
counted. Injury was measured both as a continuous variable
(i.e., the number of damaged voxels within the ROI) and as
a dichotomous variable (the ROI was injured or not).
Corticospinal tract injury: Using the diffusion-weighted
images, white matter integrity within the CST was quan-
tified as mean FA [25] within a peduncular ROI, using FSL
(www.fmrib.ox.ac.uk/fsl). Diffusion data were corrected
for eddy currents and head motion using a 3D affine reg-
istration. Fractional anisotropy maps were then generated
by fitting a diffusion tensor model at each voxel (DTIFIT
module in FSL). An ROI was then drawn on the axial slice
that showed the greatest cross-sectional area of the cerebral
peduncle (CP) [26, 27]. The colorized FA image [28] was
used to guide ROI drawing, ensuring ROIs did not extend
into the substantia nigra. The region of the CP was selected
for this measure because of its large content of descending
motor fibers and because it was located remotely from all
but one of the subjects’ stroke lesions.
A second method was used to measure corticospinal
tract injury: the amount of overlap in MNI stereotaxic
space between each subject’s infarct and the normal M1
corticospinal tract [29–31]. The normal tract was generated
using diffusion tensor tractography in 17 healthy controls
as described previously [29]. In sum, in these 17 subjects,
after DTI images were corrected for eddy current distor-
tions and head motion artifacts, FSL’s BEDPOSTX pro-
gram was used to generate probability distributions of
1180 J Neurol (2014) 261:1178–1186
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diffusion parameters at each voxel, including modeling for
diffusion of crossing fibers along two directions. Seed
regions for tractography were placed in the precentral
gyrus, and a second seed ROI was placed in the cerebral
peduncles. Tractography was initiated from a mask of the
precentral gyrus using the CP as a waypoint mask. The
resulting tracts were transformed into MNI space, bina-
rized, and summed to create a group corticospinal tract.
This tract was then thresholded to include only voxels in
which at least 6 of the subjects were included. To simulate
damage to groups of axons, the CST was divided into 16
separate longitudinal subsections. The binary stroke mask
was overlapped onto each CST subsection. For each sub-
ject with stroke, a CST subsection was classified as injured
if more than 5 % of that subsection overlapped with the
binary stroke mask. The percentage of CST injury was
calculated from the summed number of damaged subsec-
tions divided by the total number of subsections, which was
then converted to a percentage.
Cortical function
Image acquisition: Three runs of blood oxygenation level-
dependent (BOLD) images were acquired for functional
MRI (fMRI) using the following parameters:
TR = 2,000 ms, TE = 30 ms, 31 slices with thickness
4 mm, and 1-mm interslice gap. Each of the three fMRI
runs was 96 s (48 brain volumes), during which subjects
viewed a video that guided the paretic hand to alternate
between 24 s of grasp-release movements and 24 s of rest.
An investigator observed movements during scanning to
ensure compliance. Three measures of brain function were
extracted from fMRI images: (1) activation beta (contrast)
estimate; (2) activation volume, each measured in right and
in left M1 and PMd; and (3) activation laterality index (LI)
for M1 and PMd.
Functional data from the three BOLD fMRI runs were
preprocessed using SPM8 software (http://www.fil.ion.ucl.
ac.uk/spm/software/spm8). Preprocessing steps included
realignment to the first image, coregistration to the mean EPI
image, normalization to the standard MNI EPI template, and
spatial smoothing (FWHM = 8 mm). Data were visually
inspected for head movement after the realignment step.
Data were rejected for subjects with[2 mm head displace-
ment, and as a result, fMRI data for 7 subjects were excluded.
For statistical analysis, the fMRI data were modeled as a
boxcar convolved with a hemodynamic response. A high-
pass filter of 128 s was used to remove low signal changes.
Functional run data were inspected for outliers due to
excessive head motion ([1 mm translation or[0.2 radians
rotation between each volume) and signal noise (Z [ 3
from the mean image intensity) using the Artifact Detec-
tion Tool toolbox (http://www.nitrc.org/projects/artifact_
detect). Any outliers were deweighted during statistical
analysis. Single-subject t-maps (task versus rest) were
generated using p \ 0.001 uncorrected. Using the Marsbar
toolbox [32], right and left ROIs were created within M1
and PMd, as well as a midline supplementary motor area
(SMA) ROI, based on coordinates reported in a meta-
analysis by Mayka et al. [33]). Peak beta contrast estimates
and activation volumes were extracted in SPM8 using
small volume correction. If no suprathreshold clusters were
detected at p \ 0.001 uncorrected, small volume correction
was evaluated at p \ 0.01. Percent signal change within
the ROIs was also calculated in Marsbar.
Statistical analysis
Statistical analyses were conducted using JMP software
(version 8.0.2, SAS Institute, Inc., Cary, NC).
Correlates of impairment (loss of body functions and
structures): The above metrics were examined as inde-
pendent variables in relation to an impairment-based
dependent measure, arm motor FM score. First, bivariate
screening examined the relationship that each independent
variable had with the FM score, using two-tailed
alpha = 0.05. When possible, parametric methods were
used, with non-normally distributed variables transformed
to a normal distribution, else nonparametric methods were
used. Second, multivariate modeling was used. For each of
the 6 categories of measurement, if at least 1 independent
variable showed a significant bivariate relationship, the
variable with the strongest correlation in that category was
advanced into a stepwise forward multivariate model
(using p = 0.1 to enter, p = 0.15 to leave).
Correlates of impairment among patients with mild
deficits: Analyses were repeated examining only those
patients in the top quartile of FM scores (FM [ 47).
Correlates of disability (activities limitations): Analyses
were repeated using a disability-based dependent measure,
mRS score, which was dichotomized as none–slight dis-
ability (mRS score = 0–2) or moderate–severe disability
(mRS score [2).
Results
Patients
Motor impairment was on average moderate–severe
(FM = 35.0 ± 14.5, mean ± SD), with values spanning a
wide range (FM scores 14–60). A wide range of disability
was also present (mRS scores 1–4), with scores being 0–2
in 69 % of patients and[2 in 31 % of patients. One patient
was excluded from DTI analysis because the stroke directly
injured the region of interest within the cerebral peduncle,
J Neurol (2014) 261:1178–1186 1181
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7 patients were excluded from fMRI analyses due to
excessive task-related head motion during scanning, and a
contraindication to TMS (generally medication-related)
was present in 16 patients, excluding neurophysiology
analyses.
Demographics/history: Features for the 36 patients are
presented in Table 2.
Cognitive/mood status: Overall, patients were not cog-
nitively impaired or depressed (Table 2).
Genetics: Genotype frequencies were in Hardy–Wein-
berg equilibrium. The BDNF val66met polymorphism and
ApoE4 allele were present in 31 and 22 % of patients,
respectively.
Neurophysiology: The 20 patients able to undergo TMS
did not significantly differ from the 16 patients who could
not in terms of age, FM score, or time post-stroke. An MEP
could be elicited in only 5 of the 20 patients, and so TMS
findings are presented dichotomously (MEP present/
absent), as insufficient data were available to analyze the
continuous TMS measure MEP amplitude.
Brain injury: Infarct volumes were moderate on average
(31.7 ± 48.6 cc) and spanned a wide range (0.5–178 cc).
The infarcts involved M1 in 42 %, PMd in 33 %, and any
cortical gray matter in 72 % of patients (among whom
volume of cortical injury averaged 26.8 ± 37.2 cc).
Extensive CST injury was present by both methods. First,
lesion–CST overlap was 51.6 ± 32 %, indicating sub-
stantial CST injury, with the full range of values (0–100 %)
present. Second, DTI-derived values for mean FA within
ipsilesional cerebral peduncle were lower compared to
contralesional peduncle (0.37 ± 0.12 vs. 0.56 ± 0.10,
p \ 0.0001), indicating reduced ipsilesional CST integrity.
Cortical function: Paretic hand movement was generally
associated with bilateral motor system activation. Ipsile-
sionally, significant activation was present within M1 in
93 % and within PMd in 90 % of patients; contralesionally,
M1 activation was present in 90 %, and PMd in 100 % of
patients. Functional activation in ipsilesional M1 was lar-
ger than in contralesional M1 (p \ 0.004) or ipsilesional
PMd (p \ 0.002), whether examining beta estimates or
activation volumes. Overall, activation was lateralized
toward the ipsilesional hemisphere for M1
(LI = 0.41 ± 0.85) and contralesional hemisphere for
PMd (LI = -0.19 ± 0.87).
Correlates of impairment
In 4 of the 6 assessment categories (demographics/medical
history, cognitive/mood, neurophysiology, and brain
injury), bivariate screening found a single independent
variable to be significantly associated with FM score
(Table 3): greater impairment (lower FM score) was asso-
ciated with presence of hypertension, poorer cognitive
Table 3 Bivariate correlations of variables with motor impairment
and disability
Assessment Correlation
with greater
impairment
(lower FM
score)
Correlation
with greater
disability
(higher mRS
score)
r p r p
Demographics/medical history
Age 0.005 0.98 0.08 0.59
Time post-stroke 0.25 0.14 0.21 0.16
Gender 0.08 0.66 0.13
Diabetes mellitus (Y/N) 0.15 0.41 0.04a
Hypertension (Y/N) -0.49 0.0032b 0.15
Hypercholesterolemia (Y/N) -0.16 0.34 0.72
Cognitive/mood
Mini-Mental State Exam -0.34 0.048a -0.38 0.01a
Geriatric Depression Scale 0.11 0.51 0.04 0.81
Genetic
BDNF val66met polymorphism
present (Y/N)
-0.08 0.57 1.00
ApoE4 allele present (Y/N) -0.09 0.55 0.68
Neurophysiology (n = 20)
Presence of motor evoked potential
(Y/N)
-0.74 0.003b 1.00
Brain injury
Infarct volume (cc) 0.27 0.12 0.41 0.007b
M1 injury (Y/N) 0.26 0.14 0.03a
M1 injury (cc) 0.30 0.08 0.16 0.29
PMd injury (Y/N) 0.19 0.25 0.12
PMd injury (cc) 0.18 0.30 0.09 0.54
Total cortical injury (cc) 0.26 0.12 0.40 0.009b
Corticospinal tract integrity
(ipsilesional FA)
-0.60 0.0001c -0.52 0.0005c
Percent injury to CST (lesion overlap
with CST)
0.27 0.11 0.24 0.10
Cortical function (n = 29)
Ipsilesional M1 activation: beta
estimate
-0.01 0.94 -0.12 0.46
Ipsilesional PMd activation: beta
estimate
-0.03 0.87 -0.10 0.54
Contralesional M1 activation: beta
estimate
0.30 0.12 0.10 0.57
Contralesional PMd activation: beta
estimate
0.04 0.82 0.26 0.12
Ipsilesional M1 activation volume -0.10 0.60 -0.21 0.20
Ipsilesional PMd activation volume -0.23 0.22 -0.04 0.82
Contralesional M1 activation volume 0.16 0.42 0.10 0.54
Contralesional PMd activation
volume
-0.02 0.93 0.07 0.68
Activation laterality in M1 -0.18 0.39 -0.28 0.13
Activation laterality in PMd -0.30 0.19 -0.25 0.20
M1 Primary motor cortex, PMd dorsal premotor cortex, FA fractional
anisotropy
Correlation between independent variable and outcome measure (a P \ 0.05,
b P \ 0.01, c P \ 0.001)
1182 J Neurol (2014) 261:1178–1186
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status, lower CST integrity (Fig. 1a), and absence of MEP
(Fig. 1b). In 2 of the 6 categories (genetic and cortical
function), no independent variable showed a significant
bivariate relationship with impairment (FM score); the latter
remained true when fMRI analyses were repeated excluding
patients with direct stroke-related injury to M1 or PMd.
The 4 independent variables identified in bivariate
screening were advanced into a multivariate model, where
2 of these (MEP absent and lower CST integrity by DTI)
survived as significant predictors of greater impairment in
the final model (r2 = 0.71, p \ 0.0001). Note that these 2
independent variables were not correlated (p [ 0.1).
Correlates of impairment among patients with mild
deficits
Analyses were repeated examining only the 9 patients in
the top quartile of FM scores (FM score[ 47). In bivariate
screening, only one category had an independent variable
significantly related to FM score, cortical function, where 3
instances were present: greater impairment was associated
with a higher beta estimate in contralesional M1
(p = 0.017), higher beta estimate in contralesional PMd
(p = 0.02), and greater lateralization of PMd activation
toward the contralesional hemisphere (p = 0.0496).
Because all significant independent variables in bivariate
analyses were from the same category, multivariate mod-
eling was not pursued.
Correlates of disability (activities limitations)
When the 6 categories of independent variables were
examined in relation to disability (mRS score), rather than
impairment, a different pattern of findings emerged
(Table 3). Bivariate screening identified independent vari-
ables significantly associated with mRS score in three
categories: demographics/medical history (one instance),
cognitive/mood (one instance), and brain injury (three
instances). Specifically, greater disability (higher mRS
score) was associated with presence of diabetes mellitus,
poorer cognitive status (lower MMSE score), larger infarct
volume, presence of M1 injury, larger cortical injury, and
lower CST integrity by DTI.
The most significant independent variable from each of
the 3 categories identified in bivariate screening was
advanced into a multivariate model. Two of these, poorer
cognitive status and lower CST integrity, survived as sig-
nificant predictors of greater disability in the final model
(r2 = 0.42, p = 0.0001). Note that these 2 independent
variables were not correlated (p [ 0.1).
Discussion
Stroke is a very heterogeneous disease, and so not sur-
prisingly numerous measures have been found to be asso-
ciated with behavioral outcome. The current study used a
multimodal approach to determine which measures are
most strongly related to outcome by examining 6 catego-
ries in parallel. Greater impairment was most strongly
related to measures of injury (lower CST integrity) and
neurophysiological status (absent MEP), a pattern overall
consistent with preclinical studies. Results differed when
examining only patients with mild deficits, where measures
of cortical function were most important, or when exam-
ining correlates of disability, where poorer cognitive status
emerged as important. The correlates of outcome after
stroke vary according to the patient subgroup or behavioral
endpoint studied, a finding that may be important to many
aspects of clinical trial design such as choice of entry cri-
teria, stratifying variable, or biomarker.
Fig. 1 Across all patients, the strongest bivariate relationships found
with greater impairment (lower FM score) were a a measure of injury,
lower CST integrity by FA (r = 0.60, p = 0.0001); and b a measure
of neurophysiology, presence of MEP (r = 0.74, p = 0.003). These
two measures remained significant in multivariate modeling
J Neurol (2014) 261:1178–1186 1183
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Motor impairment was most strongly related to injury
and neurophysiology. The injury measure, CST integrity
using the DTI-based measure FA, reflects reduction in the
directionality of water diffusion after stroke [34]. The
correlation between lower CST integrity (lower FA) and
poorer motor outcome (lower FM score) is consistent with
prior studies [9, 35]. The neurophysiology measure, loss of
MEP, reflects reduced function across motor cortex, CST,
and motor unit [36]. The correlation between absent MEP
and poorer motor outcome after stroke has also been
reported [37]. The finding that CST integrity and neuro-
physiological status are the two factors mostly strongly
related to motor impairment after stroke is in direct
agreement with a study by Stinear et al. [38] that examined
4 of the 6 current measurement categories in 21 patients
with chronic stroke. Measures of brain injury and of neu-
rophysiology provide complementary insights after stroke:
CST integrity by DTI was not correlated with neuro-
physiological status in the current cohort or in other pop-
ulations [39, 40]; both measures remained significant in the
multivariate model; and the multivariate model explained
substantially more variance in motor impairment
(r2 = 0.72) than did either measure alone (DTI: r2 = 0.31;
neurophysiology: r2 = 0.55). The current results are con-
cordant with findings in the preclinical literature [12, 13],
which emphasize that behavioral outcome after stroke is
related to both extent of stroke injury and degree of
residual function.
In this study, 2 variables that have previously been
correlated with motor impairment did not exhibit such a
relationship. First, infarct volume did not correlate with
motor impairment, as has been described in prior studies
[41, 42], possibly due to differences in study populations or
procedures, and moreover did correlate with disability. A
global measure of injury such as infarct volume does not
provide any information about the lesion location and so
might not be expected to provide precise insight into the
functional state of any one neural system such as the motor
system, but would be expected to correlate with global
outcome measures. On the other hand, a motor system-
specific injury measure such as CST integrity does provide
specific insights into injury location and would be expected
to correlate with motor status (FM score), as per Fig. 1a as
well as previously published reports [29, 30, 43]. Together,
the current constellation of findings support the idea that a
global measure of injury (infarct volume) correlates more
strongly with a global outcome measure (mRS score),
while a neural system-specific measure of injury (CST
integrity) correlates more strongly with an outcome mea-
sure specific to that system (arm motor FM score) [44].
Second, patients’ depression scores also did not correlate
with motor impairment. Prior studies have shown that post-
stroke depression negatively impacts outcome [45, 46].
However, the primary reason depression was not related to
motor impairment is likely because the patient sample
herein was not, on average, depressed (median GDS = 2.5,
normal = 0). Also, the demands placed upon a patient to
enroll and then participate in the study may have intro-
duced an ascertainment bias against subjects suffering from
depression.
The current results emphasize that the measures most
related to behavioral outcome after stroke vary across
patient subgroups. When analyzing only those patients with
mild deficits, greater impairment correlated with measures
of cortical function (larger contralesional activation), in
contrast with results when analyzing all patients, where
impairment was related to injury and neurophysiology
rather than cortical function. Given that greater motor
impairment after stroke has a well-established relationship
with increased activation in contralesional motor areas [10,
47], why in the current study did this relationship only
emerge in the subgroup with mild motor impairment? The
answer may rest with the fact that many previous studies
have preferentially enrolled populations at the mild end of
the impairment spectrum [14] or with small infarcts [48,
49]. This divergence of findings across patient subgroups
suggests that restorative stroke trials might benefit from use
of sliding outcomes [18], whereby the definition of treat-
ment success differs across patient subgroups. Further-
more, the current results suggest that in restorative stroke
trials, a singular approach to choosing stratification vari-
ables [50] or biomarkers [2] may be unwise.
The factors most strongly related to outcome also varied
across WHO ICF dimensions. Using disability as the
dependent measure rather than impairment resulted in a
different constellation of findings: greater disability was
associated with poorer cognitive status and reduced CST
integrity. The association between greater disability and
poorer cognitive status by MMSE is consistent with prior
studies [51]. The current findings extend this observation
and support recent models suggesting that functional status
after stroke results from an interaction between cognitive
status and motor system injury [52]. Multivariate modeling
explained much less variance in disability (r2 = 0.42) than
in impairment (r2 = 0.71), emphasizing that numerous
complex factors influence disability after stroke. Finally,
the incomplete correspondence between variables in the
disability model and the impairment model is consistent
with the fact that there is not a 1:1 relationship across
WHO ICF dimensions [15].
Several limitations exist with the current study. The
central results reflect correlation rather than causation, and
the potential impact of mediating variables is difficult to
estimate. Limited statistical power might have affected
some analyses such as genetics, where very large samples
sizes are customarily used to clearly identify relationships.
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The BDNF val66met polymorphism and the ApoE4 allele
have each been shown to correlate with stroke recovery [7,
53, 54], and each is also linked to important plasticity-
related processes [55–57]. A cross-sectional study, such as
the current one, measures final outcome whereas a longi-
tudinal study captures the actual extent of recovery and so
might better elucidate behavioral relationships with these
plasticity-related genotypes. It is also noted that safety
precautions precluded data collection in some patients,
leading to a small subset of patients with neurophysiology
data.
Conclusions
The current findings indicate that tissue injury and residual
function are each related to motor outcome after stroke.
Importantly, these relationships vary when examining dif-
ferent patient subgroups or when using an outcome mea-
sure from a different WHO ICF dimension. These findings
may be instructive for the design of restorative stroke trials.
Results also support the value of a multimodal approach for
understanding outcomes after stroke [58]. Finally, the
current findings support a body of data [50] suggesting that
a measure of injury to a specific neural system (e.g., CST
integrity) might be useful for distinguishing patient sub-
groups on a biological basis.
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